Entradas
Mostrando entradas de abril, 2017
lipidos para toxicidad por anestesicos locales
- Obtener enlace
- X
- Correo electrónico
- Otras aplicaciones
HIPEC mayoral-silva 2013 revision
- Obtener enlace
- X
- Correo electrónico
- Otras aplicaciones
Mayoral-Silva A, Ascencio-Ibarra HC Consideraciones anestésicas para citorreducción y perfusión intraoperatoria intraperitoneal de quimioterapia hipertérmica Rev Mex Anest 2013; 36 (1) Idioma: Español Referencias bibliográficas: 57 Paginas: 37-46 Archivo PDF: 772.85 Kb. [Texto completo - PDF] libre en internet
HIPEC Review Shehadri et al 2016-disponible
- Obtener enlace
- X
- Correo electrónico
- Otras aplicaciones
Indian J Surg Oncol. 2016 Jun;7(2):236-43. doi: 10.1007/s13193-016-0508-2. Epub 2016 Feb 20. Anaesthetic Considerations in the Perioperative Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Sheshadri DB 1 , Chakravarthy MR 2 . Author information Abstract Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has emerged as one of the primary modalities of treatment of diffuse peritoneal malignancies. It is a complex surgical procedure with the patients facing major and potentially life threatening alterations of haemodynamic, respiratory, metabolic and thermal balance with significant fluid losses and the perioperative management is challenging for anaesthesiologists and intensive care physicians. Though the alterations are short lived, these patients require advanced organ function monitoring and support perioperatively. The anaesthesiologist is involved i...
HIPEC kajdi et al 2014 libre en pubmed
- Obtener enlace
- X
- Correo electrónico
- Otras aplicaciones
World J Surg Oncol. 2014 May 1;12:136. doi: 10.1186/1477-7819-12-136. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. Kajdi ME , Beck-Schimmer B , Held U , Kofmehl R , Lehmann K , Ganter MT 1 . Author information Abstract BACKGROUND: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is a treatment option for selected patients with peritoneal carcinomatosis. There are limited data available on anaesthesia management and its impact on patients' outcome. Our aim was to retrospectively analyze and evaluate perioperative management and the clinical course of patients undergoing CRS/HIPEC within a three-year period. METHODS: After ethic committee approval, patient charts were retrospectively reviewed for patient characteristics, intervent...